Cancer

Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank

Refinanced Loan Extends Maturity to December 2024SEATTLE and VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences,…

1 year ago

Mendus secures third shareholder loan from Van Herk Investments

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that the Company has…

1 year ago

IN8bio’s DeltEx Gamma-Delta T Cells Show Promise in Targeting Ovarian Cancer

Preclinical results showcase the potential for the strong synergistic combination of chemotherapy and gamma-delta T cell therapy to target solid…

1 year ago

Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly Anderson

Appointment to Enhance Board’s Expertise Across Investments, Business Development and Capital Markets Kelly Anderson Hillstream BioPharma Strengthens its Board of Directors…

1 year ago

AIM ImmunoTech Reports First Quarter Financial Results and Provides Pipeline Update

– Continued execution across pipeline positions AIM to achieve multiple clinical and regulatory value-driving milestones throughout 2023– Lead clinical program,…

1 year ago

Mass General Brigham and Dana-Farber Cancer Institute collaborating with BEEAH Group to advise on a new, patient-centered health care system

Strategic collaboration supports BEEAH in creating Jawaher Boston Medical District in Sharjah, United Arab EmiratesBoston, MA, May 12, 2023 (GLOBE…

1 year ago

Mustang Bio Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

WORCESTER, Mass., May 12, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on…

1 year ago

Baudax Bio Reports First Quarter Financial Results and Provides Business Update

Table 1 FDA Required Primary Efficacy Endpoint Figure 2 Study BDX-22-006 Primary Endpoint Figure 3 Study BDX-22-006Announced Positive Top-Line Final…

1 year ago

Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference

WALTHAM, Mass., May 12, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of…

1 year ago

Vaccitech Reports First Quarter 2023 Financial Results and Recent Corporate Developments

OXFORD, United Kingdom, May 12, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC) (the Company, we or us), a clinical-stage…

1 year ago